PPD

Ernest Mario named chairman of Chimerix

Wednesday, February 20, 2013 12:25 PM

Chimerix, a Durham, N.C.-based biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, has appointed Ernest Mario, Ph.D., as chairman of its board of directors.

More... »

PPD adds new central laboratory services

Monday, February 11, 2013 10:57 AM

Global CRO Pharmaceutical Product Development (PPD) has expanded its testing capabilities at its Brussels and Singapore labs, offering clients additional microbiology, peripheral blood mononuclear cell and molecular pathology services.

More... »

inVentiv Health strengthens clinical leadership team

Monday, December 10, 2012 02:12 PM

inVentiv Health, a global provider of clinical, commercial and consulting services, has appointed Raymond Hill as executive vice president of clinical. Hill will be responsible for leading the company's clinical business segment, which includes early stage, phase II-IV and strategic resourcing.

More... »

INC Research strengthens leadership for strategic advisory services unit

Monday, December 10, 2012 01:44 PM

INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

More... »

Drug discovery services market to reach $16.6B in 2015

Monday, December 10, 2012 10:09 AM

A new report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015. That revenue forecast and others appear in “DrugDiscovery Outsourcing: World Market 2013-2023,” published in November 2012.

More... »

Society for Clinical Research Sites launches as voice of site community in shaping research enterprise

Sunday, October 14, 2012 07:00 AM

Clinical research sites now have their first-ever trade group.

More... »

PPD, GA2LEN form strategic alliance in allergic diseases

Monday, September 17, 2012 10:38 AM

Pharmaceutical Product Development (PPD), a global CRO, and the Global Allergy and Asthma European Network (GA²LEN), a multidisciplinary research network, have formed a strategic alliance in which GA²LEN will provide PPD access to the network's allergy and asthma experts and to more than 100 allergy and asthma sites in Europe.

More... »

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

PPD names David Simmons chairman and CEO

Thursday, May 24, 2012 01:19 PM

Global CRO Pharmaceutical Product Development (PPD) has named David Simmons chairman and CEO. Simmons, an experienced pharmaceutical industry executive, joins PPD from Pfizer, where he was president and general manager of the emerging markets and established products business units. Simmons joins PPD June 4 and will be based at the company’s headquarters in Wilmington, N.C.

More... »

Scottish government and PPD form strategic alliance

Friday, February 10, 2012 04:05 PM

NHS Research Scotland (NRS) and CRO Pharmaceutical Product Development (PPD) have formed an alliance designed to increase the amount of clinical research conducted in Scotland, accelerate the development of new medical therapies and enhance healthcare treatment options for the people of Scotland.

More... »